UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000037275 |
|---|---|
| Receipt number | R000042498 |
| Scientific Title | Prospective study on intraocular tamponade used for rhegmatogenous retinal detachment |
| Date of disclosure of the study information | 2019/07/05 |
| Last modified on | 2019/07/05 03:34:11 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Prospective study on intraocular tamponade used for rhegmatogenous retinal detachment
Acronym
Prospective study on intraocular tamponade used for rhegmatogenous retinal detachment
Scientific Title
Prospective study on intraocular tamponade used for rhegmatogenous retinal detachment
Scientific Title:Acronym
Prospective study on intraocular tamponade used for rhegmatogenous retinal detachment
Region
| Japan |
Condition
Condition
Rhegmatogenous retinal detachment
Classification by specialty
| Ophthalmology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
Make selection standard for intraocular tamponade
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Confirmatory
Trial characteristics_2
Others
Developmental phase
Not applicable
Assessment
Primary outcomes
Final vision acuity
Key secondary outcomes
Postoperative visual acuity , recurrence
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 16 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Patients with rhegmatogenous retinal detachment treated at Yamagata University Hospital.
Patient who could get consent.
16 years old or older.
Key exclusion criteria
Patient who has withdrawn consent.
Target sample size
100
Research contact person
Name of lead principal investigator
| 1st name | Hidetoshi |
| Middle name | |
| Last name | Yamashita |
Organization
Yamagata University
Division name
Ophthalmology
Zip code
990-9585
Address
2-2-2, Iida Nishi, Yamagata, Japan
TEL
+81-23-628-5000
hyama-tky@umin.ac.jp
Public contact
Name of contact person
| 1st name | Madoka |
| Middle name | |
| Last name | Nakamura |
Organization
Yamagata University
Division name
Ophthalmology
Zip code
990-9585
Address
2-2-2, Iida Nishi, Yamagata, Japan
TEL
+81-23-628-5000
Homepage URL
m-okochi@med.id.yamagata-u.ac.jp
Sponsor or person
Institute
Yamagata University
Institute
Department
Personal name
Funding Source
Organization
Yamagata University
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Yamagata Univercity
Address
2-2-2, Iida Nishi, Yamagata, Japan
Tel
+81-23-628-5000
m-okochi@med.id.yamagata-u.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2019 | Year | 07 | Month | 05 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2019 | Year | 05 | Month | 17 | Day |
Date of IRB
Anticipated trial start date
| 2019 | Year | 07 | Month | 01 | Day |
Last follow-up date
| 2021 | Year | 06 | Month | 30 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Air selection standard
Within 2 weeks after onset
Not strong myopia
No history of cataract surgery complications
Not proliferative vitreoretinopathy grade C or higher
Management information
Registered date
| 2019 | Year | 07 | Month | 05 | Day |
Last modified on
| 2019 | Year | 07 | Month | 05 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042498
